[go: up one dir, main page]

AU2003215298A1 - Alpha1beta1 antagonists for treatment of atherosclerosis - Google Patents

Alpha1beta1 antagonists for treatment of atherosclerosis

Info

Publication number
AU2003215298A1
AU2003215298A1 AU2003215298A AU2003215298A AU2003215298A1 AU 2003215298 A1 AU2003215298 A1 AU 2003215298A1 AU 2003215298 A AU2003215298 A AU 2003215298A AU 2003215298 A AU2003215298 A AU 2003215298A AU 2003215298 A1 AU2003215298 A1 AU 2003215298A1
Authority
AU
Australia
Prior art keywords
atherosclerosis
antagonists
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003215298A
Inventor
Antonin R. De Fougerolles
Victor Kotelianski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of AU2003215298A1 publication Critical patent/AU2003215298A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003215298A 2002-02-14 2003-02-14 Alpha1beta1 antagonists for treatment of atherosclerosis Abandoned AU2003215298A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35724902P 2002-02-14 2002-02-14
US60/357,249 2002-02-14
PCT/US2003/004927 WO2003068262A1 (en) 2002-02-14 2003-02-14 Alpha1beta1 antagonists for treatment of atherosclerosis

Publications (1)

Publication Number Publication Date
AU2003215298A1 true AU2003215298A1 (en) 2003-09-04

Family

ID=27734740

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003215298A Abandoned AU2003215298A1 (en) 2002-02-14 2003-02-14 Alpha1beta1 antagonists for treatment of atherosclerosis

Country Status (2)

Country Link
AU (1) AU2003215298A1 (en)
WO (1) WO2003068262A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1043320A1 (en) 1999-06-01 2002-09-13 Biogen, Inc. A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
PL367324A1 (en) 2001-04-13 2005-02-21 Biogen, Inc. Antibodies to vla-1
EP2034830B1 (en) 2006-05-25 2014-09-03 Biogen Idec MA Inc. Anti-vla-1 antibody for treating stroke
AU2015227462B2 (en) * 2006-05-25 2017-11-02 Biogen Ma Inc. Methods of Treating Stroke
MX370199B (en) 2012-02-16 2019-12-05 Santarus Inc Anti-vla1 (cd49a) antibody pharmaceutical compositions.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1043320A1 (en) * 1999-06-01 2002-09-13 Biogen, Inc. A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders

Also Published As

Publication number Publication date
WO2003068262A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
AU2003202924A1 (en) Variation of neural-stimulation parameters
AU2003236991A1 (en) Representations of processes
AU2003277596A1 (en) Method of deuterization
AU2003248786A1 (en) Compositions comprising panthetine for the treatment of dyslipidemia
AU2003269126A1 (en) Method of combining materials
AU2003264673A1 (en) Use of isoflavones for promoting slimming
AU2003279841A1 (en) Uses of human zven antagonists
AU2003222120A1 (en) Oxon process
AU2003233820A1 (en) Method for the treatment of starch
AU2003300904A1 (en) Antagonists for human prolactin
AUPS096002A0 (en) Method of construction
AU2003234921A1 (en) Method of knitting knit-wear
AU2003215298A1 (en) Alpha1beta1 antagonists for treatment of atherosclerosis
AU2003216848A1 (en) Deracemisation of amines
AU2003262141A1 (en) Preperation of desloratatine
AU2002951913A0 (en) Method of treatment
AU2003288576A1 (en) Rabeprazole calcium
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2003223329A1 (en) Antagonists of rf-amide neuropeptides
AU2003267800A1 (en) Methods of using ccr1 antagonists as immunomodulatory agents
AU2003208809A1 (en) Treatment of neuroblastoma
AU2003299080A1 (en) Surface treatment of concrete
AU2003255785A1 (en) Method of authentication
AU2003290512A1 (en) Method of weldbonding
AU2003235129A1 (en) Process for preparation of 2-aminoketones

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase